This ebook specializing in the immunopathology of cancers is revealed as a part of the three-quantity Springer collection Cancer Immunology, which intends to supply an up-to-date, clinically related evaluate of most cancers immunology and immunotherapy. Readers will discover complete descriptions of the interactions between cancerous cells and several other parts of the innate and adaptive immune system. The principal focus, although, may be very a lot on scientific elements, the purpose being to teach clinicians within the scientific implications of the most recent analysis and new developments within the subject. Cancer Immunology: A Translational Medicine Context, 2nd Edition, (PDF/ePub) shall be of particular worth to hematologists, scientific immunologists, and oncologists. In the brand new second version of this very effectively-acquired ebook, first revealed in 2015, the unique chapters have been significantly up to date and extra chapters included on, as an example, present information on the roles of NK cells and T-helper cells in tumor immunity, the half performed by oncoviruses within the growth of varied cancers, and the makes use of of fluorescent in situ hybridization, bioluminescence, and most cancers molecular and useful imaging. We advocate the free Adobe Digital Editions (beneficial for Mobile units) or Calibre (beneficial for Mac/Windows) to view the ePub ebook. NOTE: The product only contains the ebook, Cancer Immunology: A Translational Medicine Context, 2nd Edition in unique ePub format. A transformed PDF is obtainable on request. No access codes are included.
Sale!
Cancer Immunology: A Translational Medicine Context (2nd Edition) – PDF
eBook details
- Author: Nima Rezaei
- File Size: 196 MB
- Format: ePub
- Length: 802 Pages
- Publisher: Springer; 2nd edition
- Publication Date: January 3, 2020
- Language: English
- ASIN: B083GL6NCP
- ISBN-10: 3030308456, 3030308448
- ISBN-13: 9783030308452, 9783030308445
Original price was: $237.49.$19.00Current price is: $19.00.
Reviews
There are no reviews yet.